Literature DB >> 32526453

Dancing with reactive oxygen species generation and elimination in nanotheranostics for disease treatment.

Zijian Zhou1, Kaiyuan Ni2, Hongzhang Deng3, Xiaoyuan Chen4.   

Abstract

Reactive oxygen species (ROS) play important roles in cell signaling and tissue homeostasis, in which the level of ROS is critical through the equilibrium between ROS generating and eliminating events. A disruption of the balance leads to disease development either by a surplus or a dearth of ROS, which requires ROS-modulating strategies to overturn the defect for disease treatment. Over the past decade, there have been tremendous advances in nanomedicine centering ROS generation and/or elimination as major mechanisms to treat a variety of diseases. In this review, we will discuss the research achievements on two opposite approaches of ROS-generating and ROS-eliminating strategies for treating cancer and other related diseases. Importantly, we will highlight the conceptual and strategic advances of ROS-mediated immunomodulation, including macrophage polarization, immunogenic cell death and T cell activation, which are currently rising as one of the mainstreams of cancer therapy. At the end, the future challenges and opportunities of mediating ROS-based mechanisms are envisioned. In light of the pleiotropic roles of ROS in different diseases, we hope this review is timely to deliver a clear logic of designing principles on ROS generation and elimination for different disease treatments. Published by Elsevier B.V.

Entities:  

Keywords:  Immunomodulation; Inflammation; Nanotheranostics; Reactive oxygen species (ROS); Tumor microenvironment (TME)

Year:  2020        PMID: 32526453     DOI: 10.1016/j.addr.2020.06.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  11 in total

Review 1.  Reactive Oxygen Species-Regulating Strategies Based on Nanomaterials for Disease Treatment.

Authors:  Chenyang Zhang; Xin Wang; Jiangfeng Du; Zhanjun Gu; Yuliang Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-12-20       Impact factor: 16.806

2.  Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.

Authors:  Masanori Oshi; Shipra Gandhi; Li Yan; Yoshihisa Tokumaru; Rongrong Wu; Akimitsu Yamada; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2022-05-31       Impact factor: 4.872

3.  A Phosphatase-Mimetic Nano-Stabilizer of Mast Cells for Long-Term Prevention of Allergic Disease.

Authors:  Peihua Lin; Mengda Cao; Fan Xia; Hongwei Liao; Heng Sun; Qiyue Wang; Jiyoung Lee; Yan Zhou; Yunan Guan; Cheng Zhang; Zhiqiang Xu; Fangyuan Li; Ji-Fu Wei; Daishun Ling
Journal:  Adv Sci (Weinh)       Date:  2021-02-08       Impact factor: 16.806

Review 4.  Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases.

Authors:  Zhengyu Deng; Shiyong Liu
Journal:  Drug Deliv Transl Res       Date:  2021-04-15       Impact factor: 4.617

Review 5.  Nanomedicine potentiates mild photothermal therapy for tumor ablation.

Authors:  Zijun Jiang; Tianyi Li; Hao Cheng; Feng Zhang; Xiaoyu Yang; Shihao Wang; Jianping Zhou; Yang Ding
Journal:  Asian J Pharm Sci       Date:  2021-10-15       Impact factor: 6.598

Review 6.  Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer.

Authors:  Yuan Cai; Kewa Gao; Bi Peng; Zhijie Xu; Jinwu Peng; Juanni Li; Xi Chen; Shuangshuang Zeng; Kuan Hu; Yuanliang Yan
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

Review 7.  Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells.

Authors:  Xuemei Yao; Wei Li; Chuyu Xiao; Xiao Wu; Menghuan Li; Zhong Luo
Journal:  Adv Sci (Weinh)       Date:  2021-10-10       Impact factor: 16.806

8.  Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells.

Authors:  Changcheng Wang; Jia Guo; Zeng'An Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Passively-targeted mitochondrial tungsten-based nanodots for efficient acute kidney injury treatment.

Authors:  Qiong Huang; Yuqi Yang; Tianjiao Zhao; Qiaohui Chen; Min Liu; Shuting Ji; Yan Zhu; Yunrong Yang; Jinping Zhang; Haixin Zhao; Yayun Nan; Kelong Ai
Journal:  Bioact Mater       Date:  2022-09-14

10.  Nanoscale Metal-Organic Framework Confines Zinc-Phthalocyanine Photosensitizers for Enhanced Photodynamic Therapy.

Authors:  Taokun Luo; Geoffrey T Nash; Ziwan Xu; Xiaomin Jiang; Jianqiao Liu; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2021-08-23       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.